摘要:
A method for prevention of atherosclerosis or for treatment of hyperlipidaemia or atherosclerosis comprises administering a compound or a mixture of compounds according to formula (I) ##STR1## as defined herein.
摘要:
The invention relates to new, multiply substituted diethylenetriaminepentaacetic acid derivatives, their complexes and complex salts, that contain an element of atomic numbers 20-32, 39-51 or 57-83, pharmaceutical agents that contain these compounds, their use as contrast media and antidotes, and process for the production of pharmaceutical agents.
摘要:
A method for prevention of atherosclerosis or for treatment of hyperlipidaemia or atherosclerosis comprises administering one of more pyridoxine derivatives to a host in need thereof.
摘要:
5-Hydroxyacetamido-2,4,6-triido-isophthalic acid-(2,3-dihydroxy-N-methyl-propyl)-(2-hydroxy-ethyl)-diamide is outstandingly suitable as x-ray contrast medium.
摘要:
The instant invention relates to guar flour formulations, to be ingested, wherein the formulations contain natural guar flour having a particle size diameter or 50 .mu.m to 1500 .mu.m and neither containing nor having been treated with any additive which substantially affects its form or consistency or which substantially delays or reduces the swelling ability of the flour.
摘要:
The invention refers to the use of N-acetylglucosamine for the therapy of degenerative diseases of the joints and of the connective and the supporting tissues as well as for the therapy of related diseases, wherein the N-acetylglucosamine is administered to the body through buccal absorption.
摘要:
Dicarboxylic acid bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) of the formula ##STR1## wherein R.sub.1 is lower straight-chain or branched-chain mono- or polyhydroxyalkyl;R.sub.2 is hydrogen, lower alkyl or R.sub.1 ;R.sub.3 is hydrogen or lower alkyl; andX is a direct bond or straight-chain or branched-chain alkylene interrupted by one or more oxygen or substituted by hydroxy or lower alkyl, are useful in x-ray contrast media.
摘要:
The invention relates to a drug-coated balloon catheter which has a catheter balloon mounted on its distal end and an expansion protection surrounding the same. The invention is characterized in that the catheter balloon is protected from premature expansion even under strong mechanical stress and in that the catheter balloon folds back more easily after dilation.
摘要:
The present invention is related to a medical device carrying at least on a portion of its surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiarectic acid, resveratrol and propyl gallate, and wherein scoring or cutting balloons as medical devices are excluded.
摘要:
The invention relates to a preparation for restenosis prevention. The preparations for restenosis prevention known as yet do not reach sufficient active agent concentrations in the affected sections of the vascular walls as higher doses cause undesirable side effects. The present invention is a preparation to which at least one antihyperplastic agent is added that has a distribution ratio between butanol and water .gtoreq.0.5. The lipophilic active agent is absorbed by the vascular wall fast and in sufficient quantity. The preparation may be a liquid that can pass through capillaries and may contain a contrast agent so that the active agent is transferred into the vascular wall without any additional effort while the usually required contrast radiograms are taken. The preparation may also be applied to a catheter.